Correlation Between Cardiff Oncology and Inovio Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardiff Oncology and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Cardiff Oncology and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Inovio Pharmaceuticals.

Diversification Opportunities for Cardiff Oncology and Inovio Pharmaceuticals

0.04

Correlation Coefficient

Cardiff Oncology  Inovio Pharmaceuticals

Significant diversification

The 3 months correlation between Cardiff and Inovio is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Inovio Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cardiff Oncology and Inovio Pharmaceuticals

Given the investment horizon of 90 days Cardiff Oncology is expected to generate 1.77 times more return on investment than Inovio Pharmaceuticals. However, Cardiff Oncology is 1.77 times more volatile than Inovio Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest  231.00  in Cardiff Oncology on September 9, 2024 and sell it today you would earn a total of  0.00  from holding Cardiff Oncology or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cardiff Oncology  vs.  Inovio Pharmaceuticals

Cardiff Oncology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Inovio Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cardiff Oncology and Inovio Pharmaceuticals

The main advantage of trading using opposite Cardiff Oncology and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.

The idea behind Cardiff Oncology and Inovio Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.